Smart Spending in Diagnostics: In-House vs. Outsourcing Strategies (The Magee Equation)
Date: Thursday June 19th, 2025, 12-1:30pm Eastern Daylight Time
Speaker
Gilbert Bigras MD, PhD, FRCPC
Edmonton, Alberta
Medical Lead Edmonton IHC Lab, Cross Cancer Institute
Associate Professor, Department of Laboratory Medicine & Pathology, University of Alberta
Dr. Gilbert Bigras is currently appointed as Associate Professor in the Department of Laboratory Medicine & Pathology in the Faculty of Medicine & Dentistry of the University of Alberta (Alberta, Canada). He is a breast pathologist working at the Cross Cancer Institute (Edmonton, Canada) and the medical IHC lead for the Edmonton Zone IHC Laboratory. He obtained a MD degree and Anatomical Pathology specialist certificate (FRCPC) at the Université de Montréal (Montréal, Canada). He obtained a PhD degree in Biomedical Engineering (Grenoble, France). His current research interest is the utilization of Artificial Intelligence applied to Biomarkers.
Host & Moderator
Carol C. Cheung MD, PhD, JD, FRCPC
Deputy Director, Canadian Biomarker Quality Assurance
Learning Objectives:
After this episode, the participant will be able to:
- Define the Magee Equation and its significance in health economics.
- Explain the differences between outsourcing Oncotype Dx testing and conducting it in-house, particularly regarding cost implications.
- Illustrate a proposed application of the Magee Equation to real-world scenarios involving Oncotype Dx testing in Alberta.